If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Osirium Technologies plc

31 Aug 2023 14:02

Form 8.3 - Osirium Technologies plc

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:OCTOPUS INVESTMENTS LTD
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeOsirium Technologies plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure30/08/2023
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security: Ordinary 5p
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled: 1,547,550 1.26  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:1,547,5501.26  

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
    

 

(b) Cash-settled derivative transactions

 

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

 

(ii) Exercise

 

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?NO

 

 

Date of disclosure:31/08/2023
Contact name:Ben Tyson
Telephone number:020 3142 4081

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
16th Mar 20225:50 pmRNSHolding(s) in Company
14th Mar 20224:40 pmRNSSecond Price Monitoring Extn
14th Mar 20224:35 pmRNSPrice Monitoring Extension
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
10th Mar 20222:16 pmRNSHolding(s) in Company
10th Mar 202211:06 amRNSSecond Price Monitoring Extn
10th Mar 202211:00 amRNSPrice Monitoring Extension
10th Mar 202210:50 amRNSHolding(s) in Company
7th Mar 20224:44 pmRNSHolding(s) in Company
7th Mar 202212:15 pmRNSResult of General Meeting
2nd Mar 20227:00 amRNSNew Customer Wins
1st Mar 20225:00 pmRNSHolding(s) in Company
28th Feb 20225:00 pmRNSTotal Voting Rights
18th Feb 20222:52 pmRNSHolding(s) in Company
11th Feb 20222:06 pmRNSSecond Price Monitoring Extn
11th Feb 20222:00 pmRNSPrice Monitoring Extension
11th Feb 202210:30 amRNSProposed Placing and Subscription and Notice of GM
14th Jan 20227:01 amRNSTrading Update
14th Jan 20227:00 amRNSChange of Adviser
29th Nov 20217:00 amRNSTrading Update
8th Nov 20217:00 amRNSChannel Partner and Marketing Update
28th Sep 20217:00 amRNSInterim Results
8th Sep 20217:00 amRNSRelease of findings from Osirium Ransomware Index
20th Aug 20217:00 amRNSChange of Auditor
22nd Jul 20212:30 pmRNSResult of AGM
11th Jun 20217:00 amRNSFinal Results
1st Jun 20217:00 amRNSTotal Voting Rights
21st May 20214:00 pmRNSHolding(s) in Company
20th May 20219:05 amRNSHolding(s) in Company
19th May 20214:24 pmRNSHolding(s) in Company
12th May 20215:16 pmRNSResults of General Meeting
4th May 20217:00 amRNSTotal Voting Rights
30th Apr 202112:43 pmRNSHolding(s) in Company
29th Apr 20216:30 pmRNSHolding(s) in Company
29th Apr 20216:29 pmRNSHolding(s) in Company
27th Apr 20217:00 amRNSPublication of Circular & Notice of GM
23rd Apr 20217:00 amRNSResult of Placing and Subscription & TVR
22nd Apr 20214:41 pmRNSProposed Placing and Subscription & Notice of GM
11th Mar 20217:00 amRNSNHS Trust Customer Wins
1st Feb 20217:00 amRNSNew Patent Granted
15th Jan 20217:00 amRNSTrading Update
9th Dec 20207:00 amRNSContract win with additional UK Ambulance Service
4th Dec 20207:00 amRNSGrant of Options
2nd Dec 202011:05 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20209:05 amRNSSecond Price Monitoring Extn
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSContract win with major UK communications provider
10th Nov 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.